Tuesday, August 13, 2019

Session III: Strategies for Targeting Aberrant Lipid Signaling in Cancer


Session Chair: John Stafford, MD, PhD

7:30-8:30 AM Breakfast Buffet (Grand Ballroom Foyer)

9:00 AM “The Role of Lipid Metabolism in Antiangiogenic Drug Resistance” - Yihai Cao, PhD, Karolinska Institute – Sweden

9:35 AM “Altered Lipid Metabolism in Myc-Transformed Cancers” - Celeste M. Simon, PhD, University of Pennsylvania – USA

10:25 AM Break

10:00 AM “Long Chain Fatty Acid Metabolism is a Critical Epigenetically-Driven Dependency in Glioma Stem Cells” - Jeremy Rich, MD, University of California - San Diego – USA

10:30 PM “Mutant GNAS Drives Pancreatic Cancer Progression via Lipid Metabolic Reprogramming” - Nabeel Bardeesy, PhD, Massachusetts General Hospital – USA

11:00 AM “Title - To Be Determined - Selected From Abstracts” - Young Investigator Short Talk

11:15 AM “Title - To Be Determined - Selected From Abstracts” - Young Investigator Short Talk

12:00 PM Lunch (Mountain View Patio)

1:15 PM Introduction and Presentation of the Roger Davis Lecturer - Robert H. Eckel, MD, University of Colorado Anschutz Medical Campus

1:20 PM Roger Davis Lecture: “Title - To Be Determined” -

1:50 PM “Introduction and Presentation of the Journal of Lipid Research (JLR) Junior Investigator Awardntroduction and Presentation of the Journal of Lipid Research (JLR) Junior Investigator Award

1:55 PM JLR Junior Investigator Award Lecture: “Regulation of PCSK9 and LDLc by Glucagon Signaling” - Lale Ozcan, MD, Columbia University – USA

2:20 PM “Use of Lipoproteins as Fuel for Immune Cells” - Alison Kohan, PhD, University of Connecticut – USA

2:50 PM Afternoon Break